A Study of LY2216684 and Theophylline in Healthy Subjects

NCT01263106 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

21

Enrollment

INDUSTRY

Sponsor class

Conditions

Major Depressive Disorder

Interventions

DRUG: LY2216684
DRUG: Theophylline

Sponsor

Eli Lilly and Company